Your browser doesn't support javascript.
loading
Moderate anemia at diagnosis is an independent prognostic marker of the EUTOS, Sokal, and Hasford scores for survival and treatment response in chronic-phase, chronic myeloid leukemia patients with frontline imatinib.
Ko, Po-Shen; Yu, Yuan-Bin; Liu, Yao-Chung; Wu, Yi-Tsui; Hung, Man-Hsin; Gau, Jyh-Pyng; Liu, Chia-Jen; Hsiao, Liang-Tsai; Chen, Po-Min; Chiou, Tzeon-Jye; Liu, Chun-Yu; Liu, Jin-Hwang.
Afiliação
  • Ko PS; a Division of Hematology and Oncology, Department of Medicine , Taipei Veterans General Hospital , Taipei , Taiwan.
  • Yu YB; b School of Medicine , National Yang-Ming University , Taipei , Taiwan.
  • Liu YC; b School of Medicine , National Yang-Ming University , Taipei , Taiwan.
  • Wu YT; c Division of Oncology and Hematology, Department of Internal Medicine , Far Eastern Memorial Hospital , Taipei , Taiwan.
  • Hung MH; a Division of Hematology and Oncology, Department of Medicine , Taipei Veterans General Hospital , Taipei , Taiwan.
  • Gau JP; b School of Medicine , National Yang-Ming University , Taipei , Taiwan.
  • Liu CJ; d Department of Nursing , Taipei Veterans General Hospital , Taipei , Taiwan.
  • Hsiao LT; b School of Medicine , National Yang-Ming University , Taipei , Taiwan.
  • Chen PM; e Division of Medical Oncology, Department of Oncology , Taipei Veterans General Hospital , Taipei , Taiwan.
  • Chiou TJ; a Division of Hematology and Oncology, Department of Medicine , Taipei Veterans General Hospital , Taipei , Taiwan.
  • Liu CY; b School of Medicine , National Yang-Ming University , Taipei , Taiwan.
  • Liu JH; a Division of Hematology and Oncology, Department of Medicine , Taipei Veterans General Hospital , Taipei , Taiwan.
Curr Med Res Opin ; 33(10): 1737-1744, 2017 10.
Article em En | MEDLINE | ID: mdl-28715941

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib / Anemia Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mielogênica Crônica BCR-ABL Positiva / Mesilato de Imatinib / Anemia Idioma: En Ano de publicação: 2017 Tipo de documento: Article